You are not currently logged in.
Access JSTOR through your library or other institution:
Vancomycin‐Resistant Enterococci in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1999‐2005
Marianna Ofner‐Agostini , MHSc, B. Lynn Johnston , MD, Andrew E. Simor , MD, John Embil , MD, Anne Matlow , MD, Michael Mulvey , PhD, Debbie Ormiston , CIC, John Conly , MD and Canadian Nosocomial Infection Surveillance Program
Infection Control and Hospital Epidemiology
Vol. 29, No. 3 (March 2008), pp. 271-274
Published by: Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Stable URL: http://www.jstor.org/stable/10.1086/528812
Page Count: 4
You can always find the topics here!Topics: Infections, Health sciences, Surveillance, Patient surveillance, Public health, Specimens, Infectious diseases, Hospital admissions
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Surveillance for vancomycin‐resistant enterococci (VRE) in sentinel Canadian hospitals has been conducted since 1999. From 1999 to 2005, the rate of VRE detection increased from 0.37 to 1.32 cases per 1,000 patients admitted, and the rate of VRE infection increased from 0.02 to 0.05 cases per 1,000 patients admitted. Thirty‐three percent of all patients with VRE detected that were reported during 1999‐2005 were identified in 2005, with increases seen in all regions of Canada. Although the incidence rate of VRE carriage in Canada is increasing, it remains very low.
© 2008 by The Society for Healthcare Epidemiology of America. All rights reserved.